Medtronic Receives FDA Approval to Launch Clinical Study for Implantable Tibial Neuromodulation Therapy for Bladder Incontinence

New Investigational Device Aims to Expand Access to Therapy for Patients with Incontinence; Underscores Medtronic's Leadership as Only Company to Offer Neuromodulation Options for Incontinence DUBLIN, April 27, 2021 -- (Healthcare Sales & Marketing Netw... Devices, Urology Medtronic, tibial neuromodulation, bladder incontinence
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news